Julie Sunderland
North Bristol NHS Trust
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julie Sunderland.
Journal of Applied Microbiology | 2003
Anne A. Delsol; Muna F. Anjum; Martin J. Woodward; Julie Sunderland; John M. Roe
Aims: To investigate the effect of a therapeutic and sub‐therapeutic chlortetracycline treatment on tetracycline‐resistant Salmonella enterica serovar Typhimurium DT104 and on the commensal Escherichia coli in pig.
Journal of Applied Microbiology | 2005
Anne A. Delsol; L. P. Randall; S. W. Cooles; Martin J. Woodward; Julie Sunderland; Joe M Roe
Aim: To assess the effect of the growth promoter avilamycin on emergence and persistence of resistance in enteric bacteria in the pig.
International Journal of Surgery | 2012
A. M. Lovering; Julie Sunderland
BACKGROUND The purpose of this study is to evaluate how wetting of Collatamp (a gentamicin-containing collagen implant [GCCI]) impacts on the gentamicin content of the implant and whether this affects its potential antibacterial efficacy. METHODS GCCI (Collatamp(®), EUSA Pharma [Europe], Oxford, United Kingdom) containing 130 mg gentamicin and 280 mg collagen (10 cm × 10 cm) were immersed in 300 mL normal saline for up to 6h. At set times after immersion the GCCI were removed, the saline diluted in normal human serum and the gentamicin content assayed by a validated immunoassay (Cedia, Microgenics Ltd, UK) to provide an estimate of the loss from each implant. The mean concentration data were then fitted to an exponential decay model (WinNonLin, Pharsight, US). RESULTS After a very short immersion period there was significant loss of gentamicin from the implants with a mean loss of 6.7% at 2 s, increasing to 40.5% at 1 min and essentially total loss by 6 h of immersion. Loss of gentamicin followed a complex elution profile, with elution half-lives ranging from 50 s on initial immersion to 99 min late in the elution period. CONCLUSION This study provides clear evidence that even a short period of dipping of Collatamp implants, and probably other GCCI, before insertion into the patient results in a significant loss of gentamicin which may be of clinical significance unless the period of soaking is very short. We therefore recommend that wetting of these implants before insertion is not undertaken.
Journal of Antimicrobial Chemotherapy | 2001
C. M. Tobin; Julie Sunderland; L. O. White; A. P. MacGowan
Journal of Antimicrobial Chemotherapy | 2004
Anne A. Delsol; Julie Sunderland; Martin J. Woodward; Lillian Pumbwe; Laura J. V. Piddock; John M. Roe
Journal of Antimicrobial Chemotherapy | 2001
Julie Sunderland; Caroline M. Tobin; Alan J. Hedges; Alasdair P. MacGowan; L. O. White
International Journal of Antimicrobial Agents | 2004
Julie Sunderland; A. M. Lovering; Caroline M. Tobin; Alasdair P. MacGowan; John M. Roe; Anne A. Delsol
Journal of Antimicrobial Chemotherapy | 1998
C. M. Tobin; Julie Sunderland; L. O. White; A. P. MacGowan; D. S. Reeves
Journal of Antimicrobial Chemotherapy | 2003
Julie Sunderland; A. M. Lovering; Caroline M. Tobin; Alasdair P. MacGowan; John M. Roe; Anne A. Delsol
Journal of Antimicrobial Chemotherapy | 2003
Caroline M. Tobin; Julie Sunderland; A. M. Lovering; Alasdair P. MacGowan